Should testing of donors be restricted to active Zika virus areas?

Affiliations

¹ Unit of Emerging Infectious Diseases, Institut Louis Malardé, Tahiti, 98713, French Polynesia. Electronic address: dmusso@ilm.pf.
² Materno-fetal and Obstetrics Research Unit, Department Femme-Mère-Enfant, Maternity, University Hospital, Lausanne, Switzerland; Institute of Microbiology, Faculty of Biology and Medicine, University of Lausanne and University Hospital, Lausanne, Switzerland.
³ William C Gorgas Center for Geographic Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, AL, USA.

Comment

Didier Musso et al. Lancet Infect Dis. 2016 Oct.

. 2016 Oct;16(10):1108-1109.

doi: 10.1016/S1473-3099(16)30337-1. Epub 2016 Sep 19.

¹ Unit of Emerging Infectious Diseases, Institut Louis Malardé, Tahiti, 98713, French Polynesia. Electronic address: dmusso@ilm.pf.
² Materno-fetal and Obstetrics Research Unit, Department Femme-Mère-Enfant, Maternity, University Hospital, Lausanne, Switzerland; Institute of Microbiology, Faculty of Biology and Medicine, University of Lausanne and University Hospital, Lausanne, Switzerland.
³ William C Gorgas Center for Geographic Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, AL, USA.

No abstract available

Comment on

Zika virus in semen of a patient returning from a non-epidemic area.
Mansuy JM, Pasquier C, Daudin M, Chapuy-Regaud S, Moinard N, Chevreau C, Izopet J, Mengelle C, Bujan L. Mansuy JM, et al. Lancet Infect Dis. 2016 Aug;16(8):894-5. doi: 10.1016/S1473-3099(16)30153-0. Lancet Infect Dis. 2016. PMID: 27477981 No abstract available.